Biotech

All Articles

New data demonstrate how Bayer's asundexian fell short to avoid strokes

.Bayer put on hold the stage 3 test for its element XIa prevention asundexian late last year after t...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its own numerous sclerosis (MS) med tolebrutinib to the FDA,...

Galapagos' stockpile as fund presents intent to shape its own progression

.Galapagos is happening under additional tension coming from investors. Having actually built a 9.9%...

Cell- focused Sana gathers very first CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shooting...

Allist pays off Jacobio $21M, landing job in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has acquired itself a starring character in China's KRAS market, pa...

ReNeuron leaving behind intention swap after missing out on fundraising target

.ReNeuron has signed up with the long checklist of biotechs to leave Greater london's purpose securi...

MBX apply for IPO to take challenger to Ascendis into period 3

.MBX Biosciences has included in the latest outbreak of IPO filings. The biotech, which submitted it...

FDA broadens probe right into Lykos' MDMA tests: WSJ

.For Lykos Rehabs and the company's would-be MDMA-assisted treatment for trauma (POST-TRAUMATIC STRE...

Gene publisher Tome laying off 131 laborers

.Just times after genetics editor Volume Biosciences revealed unrevealed working slices, a more clea...

Repare gives up 25% of staff as biotech halts preclinical R&ampD

.Repare Rehab is giving up an one-fourth of its labor force as the oncology biotech lessen its precl...